Zelboraf — Carefirst Caremark
7 indications indexed for this drug.
- Central Nervous System Cancers Glioma Meningioma AstrocytomaView coverage criteria
- Cutaneous Melanoma With Braf V600 Mutation E G V600e Or V600View coverage criteria
- Erdheim Chester Disease With Braf V600 MutationView coverage criteria
- Hairy Cell LeukemiaView coverage criteria
- Langerhans Cell Histiocytosis With Braf V600 MutationView coverage criteria
- Non Small Cell Lung Cancer With Braf V600e MutationView coverage criteria
- Papillary Thyroid Carcinoma With Braf V600e Mutation RefractView coverage criteria